The Complete Guide to Medical Weight Loss for Women in Singapore
Comprehensive doctor-reviewed guide to GLP-1 weight loss treatment for Singaporean women — Ozempic, Wegovy, Mounjaro, costs in SGD, hormonal considerations, and online treatment through zoey™.
At a glance
- Why Women's Weight Loss Is Different 2.
- Understanding GLP-1 Medications 3.
- Medications Compared 4.
Why Women's Weight Loss Is Different
Women face biological and social factors that make weight management uniquely challenging. Understanding these differences is essential for effective treatment.
Hormonal Factors
- Menstrual cycle fluctuations — oestrogen and progesterone affect appetite, cravings, water retention, and metabolism throughout the month
- PCOS (Polycystic Ovary Syndrome) — affects approximately 5–10% of women and causes insulin resistance, making weight loss significantly harder
- Pregnancy and postpartum — weight gain during pregnancy is normal, but post-pregnancy weight retention affects many women
- Perimenopause and menopause — declining oestrogen shifts fat distribution to the abdomen and reduces metabolic rate
- Thyroid conditions — hypothyroidism is more common in women and causes weight gain
Metabolic Differences
- Women generally have lower basal metabolic rates than men (less lean muscle mass)
- Women's bodies tend to resist calorie restriction more aggressively (evolutionary protection for pregnancy)
- Hormonal contraception can affect weight in some women
Social and Psychological Factors
- Greater societal pressure around body weight and appearance
- Higher rates of emotional eating and disordered eating patterns
- Diet culture messaging that promotes extreme, unsustainable approaches
- Caregiving responsibilities that limit time for meal preparation and exercise
Understanding GLP-1 Medications
GLP-1 (glucagon-like peptide-1) receptor agonists work by mimicking a natural gut hormone that regulates appetite and blood sugar. For women, these medications are particularly relevant because they address the hormonal hunger signals that make weight loss difficult.
How They Work
- Reduce appetite — act on brain centres controlling hunger and satiety2
- Slow gastric emptying — feel full longer after eating
- Improve insulin sensitivity — particularly beneficial for women with PCOS or insulin resistance
- Reduce cravings — many women report significantly reduced food preoccupation
Clinical Trial Data in Women
Women were well-represented in GLP-1 clinical trials (typically 50–70% of participants). Key findings:
- Semaglutide 2.4 mg: Average 14.9% body weight loss over 68 weeks2
- Tirzepatide 15 mg: Average 20.9% body weight loss over 72 weeks3
- Response rates were similar between women and men
- Additional benefits for women with PCOS: improved menstrual regularity, reduced androgen levels
Medications Compared
| Medication | Route | Frequency | Avg Weight Loss | Notes for Women |
|---|---|---|---|---|
| Semaglutide 2.4 mg (Wegovy) | Injection | Weekly | ~15% | Well-studied in women |
| Semaglutide 1.0 mg (Ozempic) | Injection | Weekly | ~10% | Lower dose option |
| Oral semaglutide (Rybelsus) | Tablet | Daily | ~8-10% | Needle-free option |
| Tirzepatide (Mounjaro) | Injection | Weekly | ~18-22% | Highest efficacy |
Hormonal Considerations for Women
GLP-1 medications interact with women's hormonal health in several important ways that require specific attention.
Contraception
GLP-1 medications delay gastric emptying, which can theoretically reduce the absorption of oral contraceptive pills. While clinical evidence of actual contraceptive failure is limited, women on oral contraception should discuss this with their doctor. Options include:
- Using additional contraception (condoms) during dose increases
- Switching to non-oral contraception (IUD, implant, injection) — absorption is not affected
- Monitoring for breakthrough bleeding, which may indicate reduced pill efficacy
Pregnancy
GLP-1 medications are contraindicated during pregnancy. Women should:
- Use reliable contraception while on treatment
- Stop medication at least 2 months before planned conception (semaglutide) or as advised by their doctor
- Inform their doctor immediately if pregnancy occurs during treatment
PCOS
GLP-1 medications may offer particular benefits for women with PCOS by improving insulin sensitivity and promoting weight loss — both of which can improve hormonal balance, menstrual regularity, and fertility1.
Menopause
Perimenopausal and menopausal women often experience metabolic changes that make weight loss harder. GLP-1 medications can be effective in this population, and the cardiovascular benefits are particularly relevant given increased cardiovascular risk after menopause.
Who Qualifies?
Eligibility criteria for women are the same as for men, with the important addition of pregnancy-related considerations.
BMI Criteria (Asian-Adjusted)
| Criteria | Eligible |
|---|---|
| BMI ≥27.5 (Asian obese) | Yes |
| BMI ≥25 + comorbidities (PCOS, diabetes, hypertension) | Yes |
| BMI <25 without comorbidities | Generally no |
Additional Qualifying Conditions for Women
- PCOS with insulin resistance
- Gestational diabetes history
- Post-pregnancy weight retention (>12 months postpartum)
Who Should NOT Use GLP-1 Medications
- Pregnant or planning pregnancy within 2 months
- Breastfeeding (limited safety data)
- Personal/family history of medullary thyroid carcinoma
- Active eating disorder (requires specialist care first)
Online Treatment Through zoey™
zoey™ provides women's health services including medical weight loss through MOH-compliant telehealth. The process is designed to be thorough, supportive, and discreet.
How zoey™ Works
- Health assessment — comprehensive online questionnaire including menstrual health, contraception, pregnancy history
- Doctor consultation — female-focused health assessment by an SMC-registered doctor
- Treatment plan — personalised medication, lifestyle guidance, and hormonal considerations
- Medication delivery — discreet delivery to your door
- Ongoing support — regular check-ins, dose adjustments, and lifestyle coaching
Cost in Singapore
| Medication | Monthly Cost (SGD) |
|---|---|
| Rybelsus (oral semaglutide) | S$300–450 |
| Ozempic (injectable semaglutide) | S$350–500 |
| Wegovy (semaglutide 2.4 mg) | S$500–700 |
| Mounjaro (tirzepatide) | S$400–650 |
zoey™ subscription plans may offer different pricing. Contact zoey™ for details.
Results Timeline
| Week | What to Expect |
|---|---|
| 1–2 | Reduced appetite, possible nausea |
| 2–4 | Early weight loss (1–2 kg), appetite notably reduced |
| 4–8 | Consistent weight loss (0.5–1 kg/week) |
| 8–16 | Dose escalation continues; steady progress |
| 16–52 | Approaching maximum weight loss |
| Note | Menstrual cycle may cause weekly weight fluctuations of 1–2 kg — track monthly trends, not weekly |
Side Effects
Side effects are similar for women and men, primarily gastrointestinal. Most improve with time and dose adjustment.
Common
- Nausea (most common during dose increases)
- Constipation or diarrhoea
- Decreased appetite (therapeutic effect)
- Headache
Women-Specific Considerations
- Menstrual changes — some women report changes in cycle regularity or flow(Based on MOH guidelines and prescribing information)
- Oral contraceptive interaction — discuss with doctor
- Hair thinning — rapid weight loss (any cause) can trigger temporary telogen effluvium; adequate protein intake and slower weight loss reduce this risk
FAQ
Some women report changes in menstrual patterns, but this is not well-studied. Weight loss itself can affect menstrual regularity. Report significant changes to your doctor.
GLP-1 medications are generally not recommended during breastfeeding due to limited safety data. Discuss timing with your doctor if you're planning to stop breastfeeding.
Facial volume loss can occur with significant weight loss (any method). Adequate protein intake, slower weight loss, and maintaining hydration can minimise this effect. It's not specific to GLP-1 medications.
Women with PCOS often respond well to GLP-1 medications. The improvement in insulin sensitivity is particularly beneficial for PCOS-related weight gain.
Yes. GLP-1 medications can be used alongside HRT for menopausal women. There are no significant drug interactions, but inform your doctor about all medications.
zoey™ is dedicated to women's health, with assessments, treatment plans, and support designed for women's specific needs. noah™ focuses on men's health. Both operate under the same clinical governance.
Rapid weight loss from any cause can trigger temporary hair shedding (telogen effluvium), typically 2–4 months after significant weight loss. It's not caused by the medication itself. Adequate protein intake and gradual weight loss minimise this risk.
Yes, but you must stop GLP-1 medication at least 2 months before trying to conceive. Weight loss before pregnancy can actually improve fertility outcomes, particularly for women with PCOS.
Yes, but discuss with your doctor. GLP-1 medications may reduce oral contraceptive absorption. Your doctor may recommend additional contraception or switching to a non-oral method.
Related Reading
Explore these in-depth guides for more information:
-
Davies MJ, Bergenstal R, Bode B, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes. JAMA. 2015;314(7):687-699. PMID: 26132939 ↩
-
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185 ↩↩↩
-
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. PMID: 35658024 ↩↩
This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription-only in Singapore. Always consult a licensed doctor before starting any treatment. zoey™ consultations are conducted by SMC-registered doctors in accordance with MOH telemedicine guidelines.